Cancer Drug's hidden heart risk: small study seeks answers
NCT ID NCT04813913
Summary
This study aimed to understand how a common cancer drug (bevacizumab/Avastin) affects the heart and blood vessels in patients with advanced colorectal cancer. Researchers measured artery stiffness and blood pressure in 13 patients before and during treatment to see if these heart-related side effects were linked to how well the cancer responded. The goal was to gather knowledge to better predict and manage these risks for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de ROUEN
Rouen, France
Conditions
Explore the condition pages connected to this study.